Skip to main content
OpenTrials

Clinical trial condition

Homozygous Familial Hypercholesterolemia

Explore clinical trials studying Homozygous Familial Hypercholesterolemia. Study availability and eligibility vary by location and protocol.

30 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Homozygous Familial Hypercholesterolemia trial results

Completed

Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia

NCT03399786

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • Regeneron Research Site Boca Raton, Florida, United States
  • Regeneron Research Site Boston, Massachusetts, United States
  • Regeneron Research Site New York, United States
  • Regeneron Research Site Cincinnati, Ohio, United States
View all 30 locations
View Trial Details
Completed

Trial Evaluating PCSK9 Antibody in Subjects With LDL Receptor Abnormalities

NCT01588496

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations
  • Research Site New York, United States
  • Research Site Cincinnati, Ohio, United States
  • Research Site Brussels, Belgium
  • Research Site La Louvière, Belgium
View all 21 locations
View Trial Details
Completed

A Safety and Efficacy Study of AEGR-733 to Treat Homozygous Familial Hypercholesterolemia (FH)

NCT00730236

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Robarts Research Institute London, Ontario, Canada
  • Lipid Clinic and University of Montreal Community Genomic Medicine Center Chicoutimi, Quebec, Canada
View Trial Details
Completed

Study to Evaluate the Effects of MBX-8025 in Patients With HoFH

NCT02472535

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • Ecogene-21 Chicoutimi, Quebec, Canada
  • Montreal Heart Institute Montreal, Quebec, Canada
  • Endocrinologie metabolisme et prevention cardiovasulaire, Institut E3M et IHU cardiometabolique (ICAN), Hôpital Pitié Salpêtrière Paris, France
  • Radbound UMC Nijmegen, Netherlands
View Trial Details
Completed

Effect of CER-001 on Plaque Volume in Homozygous Familial Hypercholesterolemia (HoFH) Subjects

NCT01412034

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • Clinical Research Facility Hartford, Connecticut, United States
  • Clinical Research Facility North Massapequa, New York, United States
  • Clinical Research Facility Chicoutimi, Quebec, Canada
  • Clinical Research Facility Québec, Quebec, Canada
View Trial Details

Related conditions